Abstract
Bipolar disorders represent an illness not easily treated by monotherapy. Approximately 2/3 of patients are not adequately responsive to lithium monotherapy and the great majority of patients require (and get) additional medication: additional mood stabilizers [1], antipsychotics [2], antidepressants, antimanic and/or hypnotic substances [3,4]. These traditional additional drugs are associated with potential problems. Antidepressants may precipitate mixed states or mania and/or cause cycle acceleration and rapid cycling. Conventional neuroleptics are associated with switching into depression, and clearly increase the individual risk of extrapyramidal symptoms, such as tardive dyskinesia. Polypharmacy is associated with the risk of unwanted pharmacological interactions: specific risks in antibipolar treatment are discussed.
Highlights
International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here.
Bipolar disorders represent an illness not treated by monotherapy
2/3 of patients are not adequately responsive to lithium monotherapy and the great majority of patients require additional medication: additional mood stabilizers [1], antipsychotics [2], antidepressants, antimanic and/or hypnotic substances [3,4]. These traditional additional drugs are associated with potential problems
Summary
International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. . Polypharmacy in bipolar disorder: does it make sense?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.